3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Mesothelioma
3
Solid Tumor, Adult
2
Solid Tumor
2
Retinoblastoma
2
Thyroid Neoplasms
1
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Pneumothorax
1
Pleural Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Parathyroid Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Hemostatic Disorders
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage III Breast Cancer AJCC v8
1
Advanced Solid Tumor
1
Adenocarcinoma
1
Interventions
Injections
26
toripalimab
17
pembrolizumab
17
tislelizumab
12
Gemcitabine
8
Cisplatin
7
spartalizumab
6
atezolizumab
6
Irinotecan
6
Carboplatin
6
Paclitaxel
5
Oxaliplatin
5
Nivolumab
5
Leucovorin
5
Fluorouracil
5
camrelizumab
4
Pemetrexed
4
Docetaxel
4
Cetuximab
4
Capecitabine
4
trastuzumab deruxtecan
3
sintilimab
3
olaparib
3
lenvatinib
3
cediranib
3
PM 01183
3
Drug Therapy
3
Cyclophosphamide
3
Bevacizumab
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
Blood Specimen Collection
×
Other solid neoplasm
×
Clear all
NCT03163732
2022-05-09
PROFILER 02
Centre Leon Berard
Phase NA
Completed
341 enrolled